Literature DB >> 22866122

Treatment strategies in intermediate cervical neoplasia: Implications of radical surgery.

K W M VAN Delft1, H J M M Mertens.   

Abstract

Treatment strategies for cervical intraepithelial neoplase (CIN)2 lesions differ among gynaecologists. To evaluate the differences in management of treatment with subsequent implications, all surgical treatment strategies and follow-up methods were retrospectively analysed for patients with intermediate dysplasia of the cervix. This study aimed to evaluate expectant management strategies and the effect of biopsy prior to radical surgery in CIN2. Patients diagnosed with a CIN2 lesion at the Orbis Medical Center in The Netherlands between 2006 and 2007 were retrospectively analysed. The follow-up ended on 1st January 2009. All 141 patients with CIN2 lesions were included; 109 had no previous history of any CIN lesion. Of the 109 patients, 12% (n=13) underwent an immediate radical surgical excision of the transformation zone (LLETZ procedure) and 85% (n=93) underwent a local biopsy. After the lesion was biopsied, expectant management was selected for 59% of the patients. Subsequent smears were normal in 40% of the patients. Of the patients with abnormal smears in follow-up, the LLETZ procedure was performed in 86% of the patients (n=25). Of these cases, persistent disease was observed in 14% of the patients. After an immediate LLETZ procedure without prior biopsy, follow-up smears were abnormal in 31% of the patients. Persistent disease was significantly lower following radical excision of the lesion with a diagnostic biopsy versus without one (14 versus 31%). After expectant management, the rate of persistent disease was 53% (p<0.001). Overall, the rate of persistent disease was 7%. Due to the high rate of persistent disease and the lower rate of overtreatment, CIN2 lesions should be treated by the excisional procedure. To restrict persistent disease, a biopsy is recommended prior to the actual treatment, since a higher rate of abnormal smears was observed in the follow-up after immediate radical excisions in the first visit.

Entities:  

Year:  2011        PMID: 22866122      PMCID: PMC3410499          DOI: 10.3892/ol.2011.289

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

1.  Cervical cancer screening in the Netherlands.

Authors:  M van Ballegooijen; R Hermens
Journal:  Eur J Cancer       Date:  2000-11       Impact factor: 9.162

2.  Diagnoses and outcomes in cervical cancer screening: a population-based study.

Authors:  Ralph P Insinga; Andrew G Glass; Brenda B Rush
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

Review 3.  Management of cervical premalignant lesions.

Authors:  B G Lindeque
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2005-03-26       Impact factor: 5.237

Review 4.  The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach.

Authors:  M Kyrgiou; I Tsoumpou; T Vrekoussis; P Martin-Hirsch; M Arbyn; W Prendiville; S Mitrou; G Koliopoulos; N Dalkalitsis; P Stamatopoulos; E Paraskevaidis
Journal:  Cancer Treat Rev       Date:  2006-09-27       Impact factor: 12.111

Review 5.  Management of histologic abnormalities of the cervix.

Authors:  Mark Spitzer; Barbara S Apgar; Gregory L Brotzman
Journal:  Am Fam Physician       Date:  2006-01-01       Impact factor: 3.292

6.  Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study.

Authors:  Ilkka Kalliala; Ahti Anttila; Eero Pukkala; Pekka Nieminen
Journal:  BMJ       Date:  2005-11-19

7.  A "see and treat" management for high-grade squamous intraepithelial lesion pap smears.

Authors:  Terry S Dunn; Mary Burke; James Shwayder
Journal:  J Low Genit Tract Dis       Date:  2003-04       Impact factor: 1.925

8.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

9.  Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

Authors:  Margaret R E McCredie; Katrina J Sharples; Charlotte Paul; Judith Baranyai; Gabriele Medley; Ronald W Jones; David C G Skegg
Journal:  Lancet Oncol       Date:  2008-04-11       Impact factor: 41.316

10.  Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature.

Authors:  M Kyrgiou; G Koliopoulos; P Martin-Hirsch; S Kehoe; G Flannelly; S Mitrou; M Arbyn; W Prendiville; E Paraskevaidis
Journal:  Cancer Treat Rev       Date:  2007-07-20       Impact factor: 12.111

View more
  2 in total

1.  Prediction value with a novel and accurate tissue-based human papillomavirus detection method in low-grade squamous intraepithelial lesions.

Authors:  He Wang; Zheng He; Xue Han; Deyu Zhang; Shitai Zhang
Journal:  Cancer Med       Date:  2022-03-28       Impact factor: 4.711

Review 2.  Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.

Authors:  Karoliina Tainio; Antonios Athanasiou; Kari A O Tikkinen; Riikka Aaltonen; Jovita Cárdenas; Sivan Glazer-Livson; Maija Jakobsson; Kirsi Joronen; Mari Kiviharju; Karolina Louvanto; Sanna Oksjoki; Riikka Tähtinen; Seppo Virtanen; Pekka Nieminen; Maria Kyrgiou; Ilkka Kalliala
Journal:  BMJ       Date:  2018-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.